1strx.com

What It Is

1stRX is a U.S.-based online telehealth platform focused on GLP-1 and GLP-1/GIP injectable weight-loss services. It is not a traditional enterprise SaaS product; rather, it is an online medical services platform that connects patients, licensed clinicians, and U.S. compounding pharmacies. After completing a health questionnaire, users are reviewed by an MD, DO, NP, or PA, who determines whether to prescribe compounded Semaglutide or Tirzepatide. Medications are then delivered to the user’s home via cold-chain shipping.

Core Capabilities and Experience

The platform’s workflow is fairly straightforward: a free assessment in about 5 minutes, an online consultation within 24 hours, and delivery within 5–7 business days after approval. Ongoing care includes monthly follow-ups, secure messaging or video communication, automatic refills, and dosage adjustments. Medications come with syringes, supplies, printed instructions, and video guidance. Its main strength is bundling consultation, prescription, pharmacy fulfillment, and long-term management into a subscription-style experience, reducing the need for in-person visits and price comparison.

Pricing and Compliance Risks

Pricing is disclosed relatively transparently: Semaglutide starts as low as $75/month for new users and then continues at $112/month; Tirzepatide starts at $149/month and then continues at $223/month. The fee includes consultation, medication, cold-chain shipping, and follow-up care, with no insurance required and cancellation allowed. However, the text repeatedly emphasizes that compounded medications are not FDA-approved drugs and are not equivalent to Ozempic, Wegovy, Mounjaro, or Zepbound. Efficacy references are based on studies of branded drugs with the same active ingredients, and individual results are not guaranteed.

Pros and Cons

The advantages are a fully online process, public pricing, no insurance requirement, clinical judgment by licensed professionals, and ongoing follow-up care. The drawbacks are that the service depends on the U.S. telehealth and pharmacy system, and the medications carry side effects and eligibility restrictions. Meanwhile, from a SaaS perspective, it does not disclose third-party integrations, team permissions, APIs, developer support, or enterprise deployment capabilities, making it difficult to evaluate as an enterprise software purchase.

Who It’s For and Access from China

It is best suited for individuals in the United States who want online medical weight-management support and meet the relevant clinical criteria. Users in China should not treat it as a cross-border medication purchasing option, as payment, prescription legality, cold-chain delivery, and medical liability may not apply. The text does not specify its accessibility from China; users should prioritize locally compliant hospitals, internet hospitals, or licensed medical institutions.